A Stability Indicating Assay Method Development and Validation for the Frovatriptan Succinate Monohydrate by Using UV: A Spectrophotometric Technique

Table 5

Photolytic degradation of FSM (𝑛=6).

Time (hours)	Concentration remaining; (𝜇g/mL ± SD)	RSD (%)	Degradation (%)
0	2.415±0.003	0.554	3.532
0.5	2.391±0.002	0.338	4.498
1	2.393±0.001	0.220	4.424
2	2.390±0.000	0.000	4.572
3	2.219±0.001	0.136	11.636
6	2.160±0.003	0.697	14.089
9	2.060±0.002	0.396	18.253
12	1.744±0.001	0.126	31.338